Polaryx Therapeutics Inc (PLYX) Annual Balance Sheets

Annual · GAAP · USD millions
Access PLYX quarterly Balance Sheets →
Balance sheet data covering Polaryx Therapeutics Inc– offers a view into how Dec 31 2025's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent5.14
Cash & Short-term Investments5.00
Other Current Assets0.03
Total Current Assets5.17
Total Assets5.17
Liabilities
Accounts Payable, Current AC0.47
Accrued Liabilities, Current AC0.02
Other Liabilities, Current0.11
Total Current Liabilities0.61
Total Long-term Debt0.00
Total Liabilities0.61
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock104.20
Retained Earnings / Accumulated Deficit-99.64
Other Equity0.00
Common Stockholder's Equity4.57
Total Stockholder's Equity4.57
Liabilities & Stockholder's Equity5.17
4 historic quarters locked

Sign in to unlock the full Polaryx Therapeutics Inc balance sheet history.

About Polaryx Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-033064

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI